AU5738996A - Gene therapy through transduction of oral epithelial cells - Google Patents

Gene therapy through transduction of oral epithelial cells

Info

Publication number
AU5738996A
AU5738996A AU57389/96A AU5738996A AU5738996A AU 5738996 A AU5738996 A AU 5738996A AU 57389/96 A AU57389/96 A AU 57389/96A AU 5738996 A AU5738996 A AU 5738996A AU 5738996 A AU5738996 A AU 5738996A
Authority
AU
Australia
Prior art keywords
transduction
gene therapy
epithelial cells
oral epithelial
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57389/96A
Inventor
Edward J. Shillitoe
Bruce Trapnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Therapy Inc
Original Assignee
Genetic Therapy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Therapy Inc filed Critical Genetic Therapy Inc
Publication of AU5738996A publication Critical patent/AU5738996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/70—Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU57389/96A 1995-05-11 1996-05-10 Gene therapy through transduction of oral epithelial cells Abandoned AU5738996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43923195A 1995-05-11 1995-05-11
US439231 1995-05-11
PCT/US1996/006648 WO1996035455A1 (en) 1995-05-11 1996-05-10 Gene therapy through transduction of oral epithelial cells

Publications (1)

Publication Number Publication Date
AU5738996A true AU5738996A (en) 1996-11-29

Family

ID=23743854

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57389/96A Abandoned AU5738996A (en) 1995-05-11 1996-05-10 Gene therapy through transduction of oral epithelial cells

Country Status (2)

Country Link
AU (1) AU5738996A (en)
WO (1) WO1996035455A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457189A (en) * 1989-12-04 1995-10-10 Isis Pharmaceuticals Antisense oligonucleotide inhibition of papillomavirus
US5631236A (en) * 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk

Also Published As

Publication number Publication date
WO1996035455A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU4786496A (en) New forms of paroxetin hydrochloride
AU6497696A (en) Electrode
AU7612196A (en) Functional human hematopoietic cells
AU5048596A (en) Improved electrode
AU5657396A (en) Cemented carbide
AU6614696A (en) Inhibition of gene expression
AU2820595A (en) Colon specific genes and proteins
AUPN313795A0 (en) Adjustment of camber
AU5848996A (en) Creation of overlapping cells when using multi casing
AU6614596A (en) Inhibition of gene expression
AU5588096A (en) Oral formulations of S(+)-etodolac
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU4954496A (en) Gene transfer preparation
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU3555295A (en) Game of chance
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU5405496A (en) Manufacture of bags
AU5747296A (en) Tab style electrode
AU4862396A (en) Human obesity gene
GB2304977B (en) Production of electrodes
AU6097896A (en) Oral delivery of gene constructs
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU5738996A (en) Gene therapy through transduction of oral epithelial cells
AU5989396A (en) Origin of replication complex genes